Publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease
November 27, 2018 08:51 ET
|
ORPHAZYME A/S
Orphazyme A/SInvestor news No....
Orphazyme reports encouraging arimoclomol clinical trial top-line data in Niemann-Pick disease Type C (NPC)
September 28, 2018 01:00 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Orphazyme to Present at 25th NPUK Annual Family Conference 2018
September 20, 2018 09:19 ET
|
ORPHAZYME A/S
Orphazyme A/SInvestor news No....
Orphazyme announces enrollment of first patient in Phase III clinical trial of arimoclomol for ALS
August 10, 2018 12:19 ET
|
ORPHAZYME A/S
Orphazyme A/SCompany announcement No....
Publication of manuscript related to Phase II trial results for arimoclomol in patients with SOD1 ALS
January 24, 2018 16:06 ET
|
ORPHAZYME A/S
Investor newsOrphazyme A/SNo. 01/2018 ...